AtriCure(ATRC) - 2024 Q2 - Quarterly Results

Exhibit 99.1 For immediate release July 30, 2024 AtriCure Reports Second Quarter 2024 Financial Results • Worldwide revenue of $116.3 million – an increase of 15.2% year over year • Positive cash flow generation of $8.1 million in second quarter 2024 MASON, Ohio, July 30, 2024 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2024 f ...